Related Experiment Video
Updated: Feb 4, 2026
Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
Published on: January 25, 2015
Subungual melanoma: A retrospective cohort of 157 cases from Brazilian National Cancer Institute
Luiz Fernando Nunes1, Gélcio L Q Mendes1, Rosalina J Koifman2
1Brazilian National Cancer Institute, Rio de Janeiro, Brazil-Connective Bone Tissue Section.
Background:
Subungual melanoma (SM) is rare. The lesions are thick at the time of diagnosis. Few studies have evaluated SM in Brazil.
Objective:
The objective of this study was to investigate the factors associated with the survival of SM patients from the Brazilian National Cancer Institute.
Methods:
One-hundred and fifty-seven patients diagnosed with SM were included in this study. We evaluated the epidemiologic, clinical, and histopathological data. Overall survival (OS) and relapse-free survival (RFS) curves were computed using the Kaplan-Meier method. Multivariable analyses were conducted using the Cox proportional hazard regression model.
Results:
Among the 157 patients, 87 (55.4%) were female. The median age was 68 years old. Median tumor depth was 6.0 mm. Lesions were ulcerated in 94 (59.9%). OS and RFS rates for 5 years were 61.0% and 41.8%, respectively. Median follow-up time was 28 months. The factors associated with OS were Breslow thickness and ulceration, and for RFS, they were the anatomical site, Breslow thickness, and ulceration.
Conclusion:
This is the largest series of SM patients. The 5-year OS and RFS rates were low (61.0% and 48.2%, respectively), and the main prognostic factors for OS were Breslow thickness and ulceration.
Related Concept Videos
01:26National Nursing Organizations I
01:30National Nursing Organizations II
The AACN emphasizes a healthy work environment through six standards to achieve an optimal patient outcome. The standards are appropriate staffing, meaningful recognition, collaboration, authentic leadership, effective communication, and decision-making. In addition, AACN provides certification programs, webinars, journals, and...
02:18Cancer
02:12What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
02:59Cancer Prevention
Some...
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...